is anonymously supported by the industry because it eliminates tariffs intermediaries that be paid in connection with intra company thereby facilitating trade these products benefiting pharmaceutic
The arrangement is unanimously supported by the pharmaceutical industry because it eliminates tariffs on inputs and intermediaries that have to be paid even in connection with intra-company trade, thereby facilitating international trade in these products and benefiting pharmaceutical companies.
is unanimously supported by the industry because it eliminates tariffs intermediaries that be paid in connection with intra-company thereby facilitating trade these products benefiting pharmaceutical companies.